首页> 外文OA文献 >Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer

【2h】

Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer

机译：频繁的ESR1和CDK途径复制乳腺癌拷贝数改变

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ahmed Basudan; Nolan Priedigkeit; Ryan J. Hartmaier; Ethan S. Sokol; Amir Bahreini; Rebecca J. Watters; Michelle M. Boisen; Rohit Bhargava; Kurt R. Weiss; Maria M. Karsten; Carsten Denkert; Jens-Uwe Blohmer; Jose P. Leone; Ronald L. Hamilton; Adam M. Brufsky; Esther Elishaev; Peter C. Lucas; Adrian V. Lee; Steffi Oesterreich;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer [J] . Basudan Ahmed, Priedigkeit Nolan, Hartmaier Ryan J., Molecular cancer research: MCR . 2019,第2期

机译：频繁的ESR1和CDK途径复制乳腺癌中的拷贝数
2. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. [J] . Remke M, Pfister S, Kox C Blood: The Journal of the American Society of Hematology . 2009,第5期

机译：童年期T-ALL的高分辨率基因组图谱揭示了频繁的拷贝数变化，影响TGF-beta和PI3K-AKT途径以及6q15-16.1处的缺失，这是不利的早期治疗反应的基因组标记。
3. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers [J] . Fran?ois Bertucci, Charlotte Rypens, Pascal Finetti, Molecular oncology. . 2020,第3期

机译：缺口和DNA修复途径更频繁地受到炎症的基因组改变而不是非炎症乳腺癌
4. Correlation Between Glycan Biomarkers of Human Breast Cancer and a Mouse Model of Metastatic Breast Cancer [C] . Maria Lorna A. de Leoz, Lawrence J. T. Young, Hyun Joo An, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2009

机译：人乳腺癌甘油生物标志物与转移性乳腺癌小鼠模型的相关性
5. Mechanisms of Action of Non-canonical ESR1 Ligand Domain Mutations Identified in Breast Cancer [D] . Gadiya, Mayur 2020

机译：乳腺癌中非规范性ESR1配体域突变的作用机制。
6. Correction to: ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis [O] . Adi Zundelevich, Maya Dadiani, Smadar Kahana-Edwin, 2020

机译：校正至：ESR1突变在新诊断为内分泌治疗的乳腺癌的转移和局部复发中很常见预后更差
7. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers [O] . François Bertucci, Charlotte Rypens, Pascal Finetti, 2020

机译：缺口和DNA修复途径更频繁地受到炎症的基因组改变而不是非炎症乳腺癌
8. Gamma Synuclein Promotes a Metastatic Phenotype in Breast Cancer and Ovarian Tumor Cells by Modulating the Rho Signal Transduction Pathway [R] . Godwin, A. K. 2003

机译：γ突触核蛋白通过调节Rho信号转导途径促进乳腺癌和卵巢肿瘤细胞的转移表型

Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅